INDENTURE, dated as of September 29, 2023, between Xeris Biopharma Holdings, Inc., a Delaware corporation, as issuer (the “Company”), Xeris Pharmaceuticals, Inc., a Delaware corporation, as guarantor (the “Guarantor”), and U.S. Bank Trust Company,...Xeris Biopharma Holdings, Inc. • September 29th, 2023 • Pharmaceutical preparations • New York
